Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1952 4
1954 1
1955 1
1956 1
1957 1
1958 4
1962 4
1963 6
1964 5
1965 3
1966 7
1967 5
1968 5
1969 3
1970 3
1971 10
1972 6
1973 7
1974 7
1975 13
1976 21
1977 23
1978 10
1979 14
1980 16
1981 14
1982 19
1983 12
1984 28
1985 25
1986 18
1987 25
1988 29
1989 27
1990 22
1991 13
1992 12
1993 17
1994 16
1995 18
1996 24
1997 17
1998 14
1999 17
2000 11
2001 16
2002 11
2003 14
2004 16
2005 4
2006 13
2007 14
2008 20
2009 13
2010 16
2011 16
2012 21
2013 13
2014 25
2015 26
2016 19
2017 27
2018 30
2019 24
2020 27
2021 27
2022 30
2023 22
2024 17
2025 34
2026 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,015 results

Results by year

Filters applied: . Clear all
Page 1
Sustained pharmacodynamic effects of S-ketamine on cortical excitability and resting-state brain activity: A randomized, placebo-controlled trial.
de Cuba CMKE, de Goede AA, van Mechelen JC, Borghans LGJM, van der Aa L, Olofsen E, Juachon MJ, Doll RJ, Gillespie A, Harmer CJ, Jacobs GE, Heuberger JAAC. de Cuba CMKE, et al. Among authors: jacobs ge. Br J Clin Pharmacol. 2026 Jun 24. doi: 10.1002/bcp.70649. Online ahead of print. Br J Clin Pharmacol. 2026. PMID: 42340194
Optimizing Research Operations and Resource Utilization in ALS Care: Insights From the Tofersen Antisense Oligonucleotide Expanded Access Protocol.
Wheeler A, Mehta K, Sanders D, Chin C, Zivalic H, Carey J, McCaffrey A, Pant P, Lewenhaupt C, Luppino S, Jacobs G, Golden S, Gifford R, Scirocco E, Keegan M, Hatem M, Yazdanian T, Uysal SP, Susco N, Schwartzman S, Branch K, Hall KE, Barnas J, Lam J, Hagar J, Hannan CA, Paganoni S, Berry JD, Garret M, Scalia J, Babu S. Wheeler A, et al. Among authors: jacobs g. Muscle Nerve. 2026 Jun 12. doi: 10.1002/mus.70310. Online ahead of print. Muscle Nerve. 2026. PMID: 42286839
Premorbid adjustment problems, negative symptoms, and cognitive impairment in a large international sample at clinical high risk for psychosis: Findings from the Accelerating Medicines Partnership-Schizophrenia.
Cowan HR, Pratt D, Shah JL, Woods SW, Alameda L, Lepage M, Shankman SA, Addington J, Arango C, Bearden CE, Bouix S, Breitborde NJK, Broome MR, Cadenhead KS, Calkins ME, Castillo-Passi RI, Chen EYH, Choi J, Conus P, Corcoran CM, Cornblatt BA, Diaz-Caneja CM, Ellman LM, Fusar-Poli P, Gaspar PA, Gerber C, Glenthøj LB, Gonçalves C, Horton LE, Hui CLM, Kambeitz J, Kambeitz-Ilankovic L, Kahn RS, Kane JM, Keshavan MS, Kim M, Kim SW, Koutsouleris N, Kwon JS, Langbein K, Mamah D, Mathalon DH, McGorry PD, Nelson B, Nordentoft M, Pasternak O, Pearlson GD, Perez J, Perkins DO, Powers AR, Rogers J, Sabb FW, Schiffman J, Shenton ME, Silverstein SM, Smesny S, Stone WS, Strauss GP, Thompson JL, Upthegrove R, Verma S, Wang J, Wolf DH, Yung A, Zhang T, Crawford C, Yassin W, Kelly S, Coleman M, Jacobs G, Lewandowski KE, Penzel N, Baker J, Cecci G, Allott K, Buccilli K, Tod S, Addamo L, Xu L; Accelerating Medicines Partnership®—Schizophrenia (AMP® SCZ); Mittal VA. Cowan HR, et al. Among authors: jacobs g. Schizophr Bull. 2025 Dec 5:sbaf197. doi: 10.1093/schbul/sbaf197. Online ahead of print. Schizophr Bull. 2025. PMID: 42113003 Free article.
1,015 results